NINDS TTO : Research and Technology Review

Collaboration Opportunities

NINDS Licensing Opportunities

Ongoing NINDS Clinical Trials

Research and Technology Review

Licensing Opportunity (full list)

Methods of Identifying and Treating Tumors that Express Erythropoietin Receptor Protein (EPO R)

Institute : National Institute of Neurological Disorders and Stroke (NINDS)

Description of Invention :

This invention describes the expression of EPO and EPO receptor in tumors in von Hippel-Landau patients and also in sporadic renal tumor patients.

Potential Areas of Application:

•Treatment and diagnosis of renal tumors in sporadic and kidney dialysis patients
•Treatment and diagnosis of multiple tumors in different organs in patients with von Hippel- Landau patients
•Treatment and diagnosis of pheochromocytomas in sporadic and hypertension patients
•Treatment and diagnosis of eye and CNS hemangioblastomas

Inventors :

Z. Zhuang et al.

Patent Status :

Patent pending, PCT/US05/33850

NIH Reference Number:

E-274-2004

Portfolios :

Cancer -Diagnostics-In Vitro
Cancer -Diagnostics

For Additional Information Please Contact:

Thomas Clouse, J.D.., Office of Technology Transfer
Phone: 301 435-4076	Email: clousetp@mail.nih.gov

For Additional Information Regarding Collaboration with the Investigator Please Contact:

Martha Lubet, Technology Transfer Specialist
Phone: 301- 435-3120	Email: lubetm@mail.nih.gov

Last Updated: 8/8/2006

NINDS Home | NINDS TTO Home | NeuroScience@NIH | Forms